... include monoclonal antibodies (which target one specific pathway, such as the cells’ ability to grow) and antibody-drug conjugates (an anticancer drug combined with an antibody to deliver the drug specifically to cancer cells).Antibody-drug conjugates include: Adcetris (brentuximab vedotin) — Approved for people with Hodgkin or non-Hodgkin lymphoma Zevalin ...
... include monoclonal antibodies (which target one specific pathway, such as the cells’ ability to grow) and antibody-drug conjugates (an anticancer drug combined with an antibody to deliver the drug specifically to cancer cells).Antibody-drug conjugates include: Adcetris (brentuximab vedotin) — Approved for people with Hodgkin or non-Hodgkin lymphoma Zevalin ...
... Ibritumomab tiuxetan (Zevalin) is a type of radioimmunotherapy that has been approved to treat relapsed or refractory follicular lymphoma.Other MedicationsAnother class of medications to treat refractory or relapsed lymphoma works by blocking a protein called phosphoinositide 3-kinase (PI3K). Many cancerous B cells need PI3K to grow and survive. ...
... Ibritumomab tiuxetan (Zevalin) is a type of radioimmunotherapy that has been approved to treat relapsed or refractory follicular lymphoma.Other MedicationsAnother class of medications to treat refractory or relapsed lymphoma works by blocking a protein called phosphoinositide 3-kinase (PI3K). Many cancerous B cells need PI3K to grow and survive. ...